Henry Schein and UPS Join with CDC Foundation To Help CDC Combat Ebola Epidemic

A host of needs have been identified to help address the unprecedented Ebola epidemic in West Africa. One vital need is personal protective equipment (PPE) such as gloves, masks and gowns, for use by public health workers and others involved in the on-the-ground response to the epidemic in the most-impacted countries of Liberia, Guinea and Sierra Leone. To help address this need, the CDC Foundation today announced a public-private partnership with Henry Schein, Inc. and UPS to provide and direct the transport of PPE to West Africa to aid in CDC’s response efforts.

CDC Foundation Receives $25 Million Donation from Mark Zuckerberg and Dr. Priscilla Chan for Ebola Response

The Ebola epidemic in West Africa is the deadliest in history, taking the lives of more than 4,000 people to date and infecting more than 8,400 individuals in the region. To provide flexible funding to help meet the most urgent on the ground needs, Facebook Founder and CEO Mark Zuckerberg and his wife Dr. Priscilla Chan today made a grant of $25 million from their donor-advised fund at Silicon Valley Community Foundation to the CDC Foundation.

HCA Gives $1 Million in Aid for Ebola Response to CDC Foundation

HCA, which operates 164 hospitals and 114 surgery centers in 20 states and England, and the CDC Foundation today announced a $1 million cash donation by HCA to the CDC Foundation to help support international Ebola epidemic response efforts involving the U.S. Centers for Disease Control and Prevention (CDC) and their work with partners on the ground in West Africa.

CDC Foundation Receives $9 Million Grant from Paul G. Allen Family Foundation for West Africa Ebola Response

The Paul G. Allen Family Foundation provided a transformational $9 million grant to the CDC Foundation. This grant will help advance the work of the U.S. Centers for Disease Control and Prevention (CDC) and local Ministries of Health to establish sustainable emergency operations centers in the most impacted countries of Guinea, Liberia and Sierra Leone.

Crimean-Congo Hemorrhagic Fever Study

Crimean-Congo Hemorrhagic Fever Study
United States of America
To research the nairovirus, Crimean-Congo hemorrhagic fever, a tick-borne viral disease, especially common in East and West Africa. With mortality rates as high as 80 percent and with no FDA approved vaccines or therapeutics, Crimean-Congo hemorrhagic fever is considered a dangerous pathogen and a serious bioterrorism threat. The project will expand the knowledge of the ovarian tumor protease domain of the nairovirus to inform control measures and vaccine development.
University of Georgia (National Institutes of Health)
CDC's National Center for Emerging and Zoonotic Infectious Diseases

The Business Case for Global Health Security

Read more

Conference Celebrates Public Health Success and Needs in Africa

Read more
Subscribe to Global Health Security